• Company
  • Overview
  • International
  • Jobs
  • Contact Us
• Sepsis & PCT
  • Introduction
  • Sepsis Epidemology
  • Sepsis Definition
  • PCT Overview
  • PCT Molecule & Kinetics
• PCT Assays
  • PCT LIA
  • PCT Clinical Performance
  • Measuring Principle
  • Assay Characteristics
  • Instruction Manual
  • Luminometer Instrument

  • PCT sensitive KRYPTOR
  • Measuring Principle
  • Assay Characteristics
  • Instruction Manual
• Cardiac Biomarkers
  • In Development
  • MR-proANP
  • MR-proADM
  • CT-proAVP
  • CT-proET-1
• Symposia
• Support
  • Contact
  • PCT Reference
  • PCT Monograph
• Links

Overview

Diagnosis - The First Step Towards A Cure

Health is the most precious possession in life. Because economic resources for the treatment of disease are limited, they must be applied as efficiently as possible so that all will benefit from medical progress. The timely and accurate diagnosis of disease is a fundamental prerequisite for targeted, effective treatment.

B·R·A·H·M·S is a leading global biotechnology company with over 400 employees committed to improving health care through the discovery and development of new, innovative biomarkers for the diagnosis, treatment and therapeutic management of severe, life-threatening diseases.

B·R·A·H·M·S develops and markets its patent-protected products worldwide to hospitals, laboratories and licensees. Headquartered near Berlin, Germany, B·R·A·H·M·S has wholly owned subsidiaries and distribution networks selling in more than 65 countries. B·R·A·H·M·S USA, Inc. is located in Annapolis, Maryland.